Compare EZPW & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EZPW | NVCR |
|---|---|---|
| Founded | 1989 | 2000 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 1996 | 2015 |
| Metric | EZPW | NVCR |
|---|---|---|
| Price | $30.17 | $16.58 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $30.67 | $28.08 |
| AVG Volume (30 Days) | 781.3K | ★ 927.8K |
| Earning Date | 05-12-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.09 | 21.79 |
| EPS | ★ 1.65 | N/A |
| Revenue | ★ $747,954,000.00 | $655,353,000.00 |
| Revenue This Year | $25.40 | $7.72 |
| Revenue Next Year | $11.33 | $6.74 |
| P/E Ratio | $18.25 | ★ N/A |
| Revenue Growth | 2.39 | ★ 8.28 |
| 52 Week Low | $16.50 | $9.82 |
| 52 Week High | $37.13 | $21.45 |
| Indicator | EZPW | NVCR |
|---|---|---|
| Relative Strength Index (RSI) | 42.04 | 47.99 |
| Support Level | $28.10 | $16.33 |
| Resistance Level | $31.80 | $18.43 |
| Average True Range (ATR) | 1.09 | 0.75 |
| MACD | -0.35 | -0.05 |
| Stochastic Oscillator | 15.51 | 40.97 |
EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buys and sells second-hand goods. The operating segments of the company are U.S. Pawn, Latin America Pawn, and Other Investments. The U.S. Pawn segment includes all pawn activities in the United States. The Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales, which are mainly collateral forfeited from pawn lending operations and used merchandise purchased from the customers.
NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.